Company: IPODW
Filing Date: 2025-04-29
Form Type: S-1/A
Source: 0001213900-25-036656
Chunk: 315

Company: Dune Acquisition Corp II
Filing Date: 2025-04-29
Form: S-1/A
Chunk 315
---
,000 in the aggregate, if the overallotment option is exercised in full), payable to the underwriters in this offering, for deferred underwriting commissions to be placed in a trust account located in the United States and released to the underwriters only upon the completion of an initial business combination, but such $0.40 per unit shall be due solely on amounts remaining in the trust account following all properly submitted shareholder redemptions in connection with the consummation of our initial business combination, not including capital retained by alternative financing agreements such as non -redemptionagreements, forward purchase agreements, equity commitment facilities, or convertible financing. In addition, we have agreed to issue to the representative of the underwriters or its designee an aggregate of 93,750 Class A ordinary shares (or up to 107,813 Class A ordinary shares if the underwriters’ over -allotmentoption is exercised in full), as part of representative compensation, which will be issued upon the consummation of this offering.

200 If we do not complete our initial business combination within the completion window and subsequently liquidate, the trustee and the underwriters have agreed that (i) they will forfeit any rights or claims to their deferred underwriting discounts and commissions, including any accrued interest thereon, then in the trust account upon liquidation, and (ii) that the deferred underwriting discounts and commissions will be distributed on a pro rata basis, including interest earned on the funds held in the trust account (net of taxes payable), to the public shareholders. Representative Shares We will issue 93,750 Class A ordinary shares (or 107,813 Class A ordinary shares if the underwriters exercise their over -allotmentoption in full) to the representative or its designee, for nominal consideration. With regard to the representative shares, the underwriters have agreed (a) not to transfer, assign or sell any such shares without our written consent until the completion of our initial business combination, (ii) to waive their redemption rights (or right to participate in any tender offer) with respect to such shares in connection with the completion of our initial business combination, and (iii) to waive their rights to liquidating distributions from the trust account with respect to such shares if we do not complete our initial business combination within 15months from the closing of this offering. The representative shares have been deemed compensation by FINRA and are therefore subject to a lock -upfor a period of 180 days immediately following the commencement of sales of this offering.